Dapagliflozin in combination with metformin was shown to be a cost-effective treatment option from a UK healthcare system perspective for patients with T2DM who are inadequately controlled on metformin alone.
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!